Copyright
©The Author(s) 2020.
World J Clin Oncol. Jun 24, 2020; 11(6): 397-404
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.397
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.397
Figure 2 Median values (absolute value cells/mL) of T helper and T cytotoxic levels at baseline and 30 d after hyperthermic intraperitoneal chemotherapy.
HIPEC: Hyperthermic intraperitoneal chemotherapy.
- Citation: Fiorentini G, Sarti D, Patriti A, Eugeni E, Guerra F, Masedu F, Mackay AR, Guadagni S. Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study. World J Clin Oncol 2020; 11(6): 397-404
- URL: https://www.wjgnet.com/2218-4333/full/v11/i6/397.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i6.397